Human medicines European public assessment report (EPAR): Duavive, oestrogens conjugated,bazedoxifene, Date of authorisation: 16/12/2014, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 38, Status: Authorised

Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Ervebo, Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live), Date of authorisation: 11/11/2019, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Increlex, mecasermin, Date of authorisation: 02/08/2007, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 17, Status: Authorised

From laboratory to patients: How the safety of medicines is ensured in the Europen Union

What we do

EMA/PE/0000232853